LINC01194 is upregulated in the HCC cell line and controls the proliferation and migration of HCC cells by interacting with the miR-655-3p/SMAD5 axis, which provides new biomarkers for HCC diagnosis and treatment [179]. This evidence concerns the gene SMAD5 and hepatocellular carcinoma.